Cority Acquires Meddbase, Innovator in Occupational Health and Enterprise Practice Management Software 23-01-2025, 19:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Blockchain Conference ‘WEB3 Toronto Summit’ set for March 23-02-2023, 21:36